ENZN Stock, Enzon Pharmaceuticals Inc Information

Enzon Pharmaceuticals, Inc. receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron R , Sylatron R , Macugen R and CIMZIA R .